ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,298.15
0.02%
US Tech 100
18,096.00
0.09%
다우존스 지수
39,896.43
0.07%
Bitcoin
66,770.69
2.35%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Stemline Therapeutics Inc (STML)

  7. Stemline Therapeutics Inc (STML) 뉴스

STML

Stemline Therapeutics (STML)

Stemline Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:STML
일자시간출처헤드라인심볼기업
2021/02/1306:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:STMLStemline Therapeutics Inc
2020/06/2222:52Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1719:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1719:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1719:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1101:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1101:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1101:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1101:10Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1101:09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1101:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:50Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:48Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1100:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1023:20Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:STMLStemline Therapeutics Inc
2020/06/1023:05Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1023:05Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
2020/06/1022:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STMLStemline Therapeutics Inc
2020/06/0506:00Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
2020/06/0221:37Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
 검색 관련기사 보기:NASDAQ:STML

최근 히스토리

LSE
10D6
LSE
SI78
Citi Fun 24
LSE
AH32
Citi Fun 24
NASDAQ
PROS
BIT
F12577
Vontobel Financial Produ...
AMEX
CNR.R
COIN
HTDFUST
Orient Walt
ASX
IDL
Industrea
COIN
SOFUSD
BITMOT
2873776
Isp Fx 4.9% Mar26 Usd
LSE
AG20
Citi Fun 24
AMEX
WFHY
WisdomTree US High Yield...
ASX
ICBHC
Industrial anmd Commerci...
LSE
SO54
Citi Fun 24
BOV
D1XC34
DXC Technology
LSE
HB04
Citi Fun 24
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유